Glycyrrhetinic Acid (CAS 471-53-4) (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.

Market Analysis and Insights: Global Glycyrrhetinic Acid (CAS 471-53-4) Market

Due to the COVID-19 pandemic, the global Glycyrrhetinic Acid (CAS 471-53-4) market size is estimated to be worth US$ 25 million in 2022 and is forecast to a readjusted size of US$ 32 million by 2028 with a CAGR of 4.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Above 98% accounting for % of the Glycyrrhetinic Acid (CAS 471-53-4) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.

Fujie Pharmaceutical, QHL Pharma, Select Botanical and Tianshan Pharmaceuticals are the leading players in licorice acid (CAS 471-53-4) market, the top 3 accounting for about 48% of the market share.

Asia-Pacific is the largest production region with a market share of about 50%, followed by Europe with about 40%.

Global Glycyrrhetinic Acid (CAS 471-53-4) Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Glycyrrhetinic Acid (CAS 471-53-4) Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Content and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Content

Above 98%

Below 98%


Segment by Application


Pharmaceutical

Cosmetic

Others


By Company


Fujie Pharmaceutical

Qinghai Lake Pharmaceutical

Select Botanical

Givaudan (Indena S.p.A.)

Alchem International

TIANSHAN Pharmaceuticals

GfN & Selco

Jiangshu Tiansheng Pharmaceutical

Gansu Fanzhi Pharmaceutical


Production by Region



North America

Europe

China

India


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina